Tinubu’s appointment of Fatima Zuntu as NBMA DG sparks backlash

The recent appointment of Fatima Zuntu as the Director-General of the National Biosafety Management Agency (NBMA) has ignited a firestorm of controversy, with stakeholders and insiders questioning her suitability for the role. President Bola Tinubu's approval of Mrs Zuntu, described as a public health professional and policy strategist, for a four-year term has been met with skepticism, particularly concerning her adherence to the statutory requirements outlined in the NBMA Act of 2015. This law mandates a minimum of 15 years of specialized experience in biodiversity, biosafety, or related disciplines, coupled with a master's degree in biological sciences.

“

We’ve not been lucky at this agency with the appointment of DGs.

Concerns are mounting that Mrs Zuntu's professional background, as publicly available, may fall short of these stringent criteria, especially regarding the depth of experience and specialized knowledge in biosafety management. The NBMA, tasked with regulating modern biotechnology, including genetically modified organisms (GMOs), plays a crucial role in safeguarding public and environmental health while navigating the often-polarized debates surrounding biotechnology in Nigeria. The agency has seen considerable leadership instability in recent years, with multiple heads appointed and removed within short spans, raising further questions about the appointment process and the agency's operational continuity.

“

This lady is just approaching 30 years old. She is not experienced at all. How do they want her to lead?

Adding to the criticism, some agency officials, speaking anonymously, have expressed dismay over experienced directors being overlooked. They highlight Mrs Zuntu's youth and perceived lack of extensive experience as significant drawbacks for leading an agency with such critical regulatory responsibilities. Public commentators have also weighed in, questioning the rationale behind an appointment that appears to prioritize other factors over the specialized expertise deemed essential for the NBMA's mandate. This controversy underscores the ongoing challenges in ensuring that leadership appointments in critical scientific and regulatory bodies are based on merit and proven competence.

“

This young woman graduated as a medical doctor in 2016. However, that’s not the crux of the matter herein. In less than 10 years, she’s worked six different jobs across six different organisations, and the highest duration she’s spent in